Wikidata

(Q53877566)

English

Alternate-day administration of pegvisomant maintains normal serum insulin-like growth factor-I levels in patients with acromegaly.

scientific article published on 7 December 2004

In more languages
default for all languages
No label defined

No description defined

Statements

title
Alternate-day administration of pegvisomant maintains normal serum insulin-like growth factor-I levels in patients with acromegaly. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15585549
retrieved
21 May 2018
reference URL
http://europepmc.org/abstract/MED/15585549

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q53877566&oldid=1231752556"